Expectation-Maximization (EM) algorithm for point estimation and variance estimation to
    the nonparametric maximum likelihood estimator (NPMLE) for 
    logistic-Cox cure-rate model with left truncation and right-
    censoring. See Hou, Chambers and Xu (2017) <doi:10.1007/s10985-017-9415-2>.

Creates 'ggplot2' Cumulative Residual (CURE) plots to check the goodness-of-fit of a count model; or the tables to create a customized version. A dataset of crashes in Washington state is available for illustrative purposes.

Fits a variety of cure models using excess hazard modeling methodology such as the mixture model proposed by Phillips et al. (2002) <doi:10.1002/sim.1101> The Weibull distribution is used to represent the survival function of the uncured patients; Fits also non-mixture cure model such as the time-to-null excess hazard model proposed by Boussari et al. (2020) <doi:10.1111/biom.13361>.

The curl() and curl_download() functions provide highly
    configurable drop-in replacements for base url() and download.file() with
    better performance, support for encryption (https, ftps), gzip compression,
    authentication, and other 'libcurl' goodies. The core of the package implements a
    framework for performing fully customized requests where data can be processed
    either in memory, on disk, or streaming via the callback or connection
    interfaces. Some knowledge of 'libcurl' is recommended; for a more-user-friendly
    web client see the 'httr' package which builds on this package with http
    specific tools and logic.

An R client for the 'currencyapi.com' currency conversion API. The API requires registration of an API key. Basic features are free, some require a paid subscription. You can find the full API documentation at <https://currencyapi.com/docs> .

The currentSurvival package contains functions for
  the estimation of the current cumulative incidence (CCI) and
  the current leukaemia-free survival (CLFS). The CCI is the 
  probability that a patient is alive and in any disease 
  remission (e.g. complete cytogenetic remission in chronic 
  myeloid leukaemia) after initiating his or her therapy (e.g. 
  tyrosine kinase therapy for chronic myeloid leukaemia). The 
  CLFS is the probability that a patient is alive and in any 
  disease remission after achieving the first disease remission.